The NCI-60 cancer cell line panel has been used over the course of several decades as an anti-cancer drug screen. This panel was developed as part of the Developmental Therapeutics Program (DTP, http://dtp.nci.nih.gov/) of the U.S. National Cancer Institute (NCI). Thousands of compounds have been tested on the NCI-60, which have been extensively characterized by many platforms for gene and protein expression, copy number, mutation, and others (Reinhold, et al., 2012). The purpose of the CellMiner project (http://discover.nci.nih.gov/ cellminer) has been to integrate data from multiple platforms used to analyze the NCI-60 and to provide a powerful suite of tools for exploration of NCI-60 data.
|Author||Augustin Luna, Vinodh Rajapakse, Fabricio Sousa|
|Bioconductor views||CellBasedAssays Cheminformatics CopyNumberVariation GeneExpression Pharmacogenetics Pharmacogenomics Software SystemsBiology Visualization aCGH miRNA|
|Maintainer||Augustin Luna <[email protected]>, Vinodh Rajapakse <[email protected]>, Fathi Elloumi <[email protected]>|
|License||LGPL-3 + file LICENSE|
|Package repository||View on Bioconductor|
Install the latest version of this package by entering the following in R:
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.